Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

IBD

Faecal calprotectin testing—the need for better standardization

Measurement of faecal calprotectin concentration is increasingly used to assess disease activity in patients with IBD. Lasson et al. have now demonstrated that calprotectin concentrations in faeces of patients with mild or moderate left-sided or extensive ulcerative colitis vary considerably and have questioned the long-term stability of calprotectin when stored at room temperature.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. van Rheenen, P. F., van de Vijver, E. & Fidler, V. Fecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis. BMJ, 341, c3369 (2010).

    Article  Google Scholar 

  2. Schoepfer, A. M. et al. Fecal calprotectin more accurately reflects endoscopic activity of ulcerative colitis than the Lichtiger Index, C-reactive protein, platelets, hemoglobin, and blood leukocytes. Inflamm. Bowel Dis. 19, 332–341 (2013).

    Article  Google Scholar 

  3. Roseth, A. G., Fagerhol, M. K., Aadland, E. & Schjønsby, H. Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study. Scand. J. Gastroenterol. 27, 793–798 (1992).

    Article  CAS  Google Scholar 

  4. Lasson, A. et al. The intra-individual variability of faecal calprotectin: A prospective study in patients with active ulcerative colitis. J. Crohns Colitis http://dx.doi.org/10.1016/j.crohns.2014.06.002.

  5. Moum, B., Jahnsen, J. & Bernklev, T. Fecal calprotectin variability in Crohn's disease. Inflamm. Bowel Dis. 16, 1091–1092 (2010).

    Article  Google Scholar 

  6. Naismith, G. D. et al. A prospective single-centre evaluation of the intra-individual variability of faecal calprotectin in quiescent Crohn's disease. Aliment. Pharmacol. Ther. 37, 613–621 (2013).

    Article  CAS  Google Scholar 

  7. García-Sánchez, V. et al. Does fecal calprotectin predict relapse in patients with Crohn's disease and ulcerative colitis? J. Crohns Colitis 4, 144–152 (2010).

    Article  Google Scholar 

  8. De Vos, M. D. et al. Consecutive fecal calprotectin measurements to predict relapse in patients with ulcerative colitis receiving infliximab maintenance therapy. Inflamm. Bowel Dis. 19, 2111–2117 (2013).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christoph Beglinger.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Burri, E., Beglinger, C. Faecal calprotectin testing—the need for better standardization. Nat Rev Gastroenterol Hepatol 11, 583–584 (2014). https://doi.org/10.1038/nrgastro.2014.154

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrgastro.2014.154

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing